dental revenue/margin compress acceler
though one-tim item drove pressur
guidanc assum stabl margin sequenti revenu
growth salesforc stabl pt
guidanc back acceler revenu margin declin exhibit
exhibit call margin stabil year compress
revenu growth quarter declin part work pdco
favor notabl complet sap implement support sale
forc stabil product custom experi cost control easi
comp hardwar compani lap transit away cerec/xray
exclus neg mix impact shift smaller scale cadcam
option back half stabil sale rep popul
visibl pace progress magnitud impact item
howev low asid seemingli stabl sale forc recent month
offer evid improv structur financ headwind
expect persist see reason think surround
environ character tougher end market growth consolid
custom base smaller posit group practice/dso space
resolv quickli given structur realiti perform improv
better execut pace improv guidanc remain
question manag guid headwind remain notabl
revis ep estim guidanc
top-lin outlook organ growth msd top-lin
guidanc exhibit price target increas reflect manag
updat remain cautiou guid
rang possibl dental outlook anim busi
grow larger top line dental dental drive ebit
consum market growth us remain subdu dental anoth
tough one hardwar growth also moder seem unlik
recov dso pressur equip purchas appetit acquir
practic custom roughli time call
improv growth tailwind stabil hardwar mix late
stabl sale forc call growth at/abov histor norm
end market dynam tougher rel histor norm impli
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
underli assumpt call substanti share gain survey work
bearish dental survey reimburs pressur call hold
reason well success small/altern sourc option seem
unlik revers price transpar reach market make call
msd/hsd growth back half seem optimist
market trend tougher us inventori headwind fade
manufactur trail result dental consum
equip continu skew wors calendar
result exhibit privat label trend critic
maintain margin environ take question coopetit
key manufactur closer forefront uneasi environ
also take point approach toward privat label penetr
q/q step-down inventori somewhat encourag
trend though like bear brunt
drawdown note dental equip unit placement grew y/i
believ chairsid stable/up slightli though much lower
mix shift cadcam di-onli
anim growth off-set dental market growth could
slow anim health growth ex-ag switch stack improv
companion anim product anim agenc switch
said macro data april/may suggest us companion
product channel appear slow earli manag note
see overal anim health market growth rang in-lin
growth though result competitor mwi/abc
cover ricki goldwass msd rang exhibit see
ah growth msd rang eas comp slower
underli ebit trend unlik declin current pace given one-tim
item dental ebit declin though one-tim item
esop inventori revalu like drove dental
pressur total ebit pressur ex-on time item still see
continu structur pressur weigh dental ebit drive total
compani ebit forese futur decad price increas leav
room price/mix compress logic stabil given
higher margin vs healthcar distribut busi see dental margin
pressur remain underli basi necessarili report
mostli price/mix pressur gross margin opex elev
new salesforc ramp low product though pace declin
moder least half declin salesforc attrit erp
improv ah ebit margin declin second consecut quarter
erp inventori revalu esop contribut faster growth
lower margin product channel though manag believ improv
greater privat label penetr given recent trend see ah margin
overal see ebit margin vs
rais estim pt reflect assumpt benefit erp
progress despit guidanc consensu remain cautiou
signific fundament rebound call clariti conclus
erp implement howev encourag top line margin trend
support cost control custom support experi
rais revenue/ep exhibit result
chang rais pt base compound-annual-growth-rate
target yield highest coverag impli ep
current multipl
organ growth acceler driven greater expect stabil
dental busi stabl share high margin area cerec
block margin improv faster expect anim health reach
ebit margin target tax reform drive corpor tax rate
multipl expand toward averag
pt base yield estim dental
busi organ growth rang anim health rang
combin normal organ growth margin remain pressur
on-going custom consolid e-commerc competit creat
price/mix headwind impli multipl contract price-to-earnings current price-to-earnings
competit heat distributor amzn/discount e-commerc
player take price core dental consum market na
dental companion anim pharma product north american
anim drive organ growth weaker
macroeconom environ combin channel shift toward online/retail
greater gener rx penetr weaker meat demand pressur anim
sale multipl move toward pharma distributor group
larg north american-bas
distributor dental anim health
product fragment consolid
custom base independ
believ like lose share
competitor dental product categori
cerec consum well
appreci market less well
appreci also lose share
anim health structur pressur
converg industri pressur
growth margin
open north american dental
equip distribut drive
dental margin declin due
over-concentr competit us
market anim health margin
de-lever balanc sheet net
capit sale effici
greater use privat label product
risk achiev price
dental util slow medicaid
on-line competit enter market later
expect
erp roll-out creat greater expect
disrupt greater expect upsid
note organ adjust agency/net-gross switch
exhibit chang forecast
guidanc
sale
sale
sale
sale
sale
sale
million except ep
acquisit impact
incom exp
compani data morgan stanley research
morgan stanley research thomson reuter
morgan stanley research thomson reuter
morgan stanley research thomson reuter
morgan stanley research thomson reuter
price target patterson base yield estim
forecast dental busi organ growth rang anim health
rang combin normal organ growth margin remain pressur
on-going custom consolid e-commerc competit creat price/mix
headwind impli multipl ep current
risk price target includ macroeconom environ weaken impact
custom spend meat product demand soften commod price increas
reduc product anim market growth on-line competit enter market
earlier expect erp roll-out creat greater expect disrupt
greater expect upsid wc benefit
incom expens
incom tax
net continu op
revenu
ep continu oper
acquisit impact
equip softwar revenu
acquisit impact
acquisit impact
acquisit impact
acquisit impact
equip softwar revenu
acquisit impact
acquisit impact
acquisit impact
total revenu
acquisit impact
